Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
1.6000 +0.2100 (+15.11%) 12:16 ET [NASDAQ]
1.6000 x 1125 1.6200 x 200
Realtime by (Cboe BZX)
1.6000 x 1125 1.6200 x 200
Realtime 1.4800 +0.0900 (+6.47%) 09:26 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4200
Day High
1.5800
Open 1.4200
Previous Close 1.3900 1.3900
Volume 1,387,821 1,387,821
Avg Vol 1,607,352 1,607,352
Stochastic %K 31.66% 31.66%
Weighted Alpha -68.70 -68.70
5-Day Change +0.2150 (+16.17%) +0.2150 (+16.17%)
52-Week Range 1.1150 - 8.2700 1.1150 - 8.2700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,314
  • Shares Outstanding, K 131,161
  • Annual Sales, $ 2,980 K
  • Annual Income, $ -195,880 K
  • EBIT $ -202 M
  • EBITDA $ -199 M
  • 60-Month Beta 1.88
  • Price/Sales 54.52
  • Price/Cash Flow N/A
  • Price/Book 1.06

Options Overview Details

View History
  • Implied Volatility 391.91% ( -91.91%)
  • Historical Volatility 115.05%
  • IV Percentile 90%
  • IV Rank 34.46%
  • IV High 1,083.12% on 02/12/25
  • IV Low 28.53% on 08/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 24
  • Volume Avg (30-Day) 59
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 4,256
  • Open Int (30-Day) 5,689

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.32
  • Number of Estimates 5
  • High Estimate -0.28
  • Low Estimate -0.35
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1150 +38.57%
on 04/09/25
Period Open: 1.9500
2.1100 -26.78%
on 04/01/25
-0.4050 (-20.77%)
since 03/21/25
3-Month
1.1150 +38.57%
on 04/09/25
Period Open: 3.1800
3.3600 -54.02%
on 02/19/25
-1.6350 (-51.42%)
since 01/22/25
52-Week
1.1150 +38.57%
on 04/09/25
Period Open: 4.7800
8.2700 -81.32%
on 05/21/24
-3.2350 (-67.68%)
since 04/22/24

Most Recent Stories

More News
Why Prime Medicine Stock Was Climbing Higher This Week

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: PRME) across recent trading sessions. According to data compiled by S&P Global...

PRME : 1.6000 (+15.11%)
Why Prime Medicine Stock Is Soaring Today

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m. ET and was up as much as 17% earlier in the day. The move up comes as the S&P...

COMP : 7.00 (+2.04%)
PRME : 1.6000 (+15.11%)
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

PRME : 1.6000 (+15.11%)
Labour Figures Due Next Week

Monday Economic Lookahead S&P final U.S. manufacturing PMI (Feb.) Construction spending ...

TGT : 95.46 (+1.79%)
GTLB : 41.71 (+1.81%)
CRWD : 373.86 (+3.08%)
AVGO : 169.34 (+1.88%)
CURA.TO : 1.18 (-1.26%)
VEEV : 214.63 (+2.17%)
PLUG : 0.8789 (+11.45%)
OKTA : 94.92 (+2.66%)
SE : 120.10 (+3.06%)
COST : 984.40 (+2.78%)
GCO : 19.33 (+0.78%)
CRC : 35.37 (+3.06%)
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

PRME : 1.6000 (+15.11%)
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

PRME : 1.6000 (+15.11%)
Analyst: Sell ‘Magnificent 7’ Stocks and Buy These 3 Dividend Stocks Instead

Analysts at Miramar Capital are advising investors to sell “Magnificent 7” and instead invest in lower-valuation, dividend-paying healthcare stocks.

NVDA : 99.39 (+2.56%)
META : 503.62 (+3.91%)
GOOGL : 151.67 (+2.71%)
AAPL : 199.99 (+3.54%)
$SPX : 5,296.63 (+2.68%)
MRK : 78.50 (+0.83%)
ABBV : 173.78 (+2.13%)
BMY : 49.81 (+1.78%)
MSFT : 366.53 (+2.06%)
TSLA : 241.46 (+6.14%)
ABT : 131.01 (+0.86%)
AMZN : 175.22 (+4.72%)
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

PRME : 1.6000 (+15.11%)
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

PRME : 1.6000 (+15.11%)
Prime Medicine to Participate in Upcoming Investor Conferences

PRME : 1.6000 (+15.11%)

Business Summary

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 1.9100
2nd Resistance Point 1.7300
1st Resistance Point 1.5600
Last Price 1.6000
1st Support Level 1.2100
2nd Support Level 1.0300
3rd Support Level 0.8600

See More

52-Week High 8.2700
Fibonacci 61.8% 5.5368
Fibonacci 50% 4.6925
Fibonacci 38.2% 3.8482
Last Price 1.6000
52-Week Low 1.1150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro